Literature DB >> 8917132

The role of SSRIs in panic disorder.

D V Sheehan1, K Harnett-Sheehan.   

Abstract

This article reviews all available studies reported in the literature or presented at national or international meetings on the efficacy of serotonin selective reuptake inhibitors and less selective serotonin uptake inhibitors in panic disorder. The research data lags behind-rather than leads-experience in everyday clinical practice. The emerging data suggest that serotonin uptake inhibitors are superior to placebo and better tolerated than most of the older alternatives. As a result they are now becoming first-choice treatments in panic disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917132

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

Review 1.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

2.  Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

Authors:  J Shlik; A Aluoja; V Vasar; E Vasar; T Podar; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 3.  Should patients be given an initial low test dose of sildenafil?

Authors:  J S Cohen
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

4.  Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.

Authors:  E Leinonen; U Lepola; H Koponen; J Turtonen; A Wade; H Lehto
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

5.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

6.  Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment.

Authors:  Alan J. Gelenberg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-04

7.  A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders.

Authors:  Steven R. Arikian; Jack M. Gorman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06

8.  Duloxetine in panic disorder with somatic gastric pain.

Authors:  Matteo Preve; Cristiana Nisita; Massimo Bellini; Liliana Dell'osso
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-21       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.